The company said Q1 2025 sales fell 7% to $9.5 billion, and net earnings were $481 million ($3.32 per diluted share). Northrop Grumman said it recognized a pre-tax loss of $477 million on 5 low-rate initial production options for the B-21 program.

1. 01

   The company said Q1 2025 sales fell 7% to $9.5 billion, and net earnings were $481 million ($3.32 per diluted share). Northrop Grumman said it recognized a pre-tax loss of $477 million on 5 low-rate initial production options for the B-21 program.

2. 02

   Northrop Grumman said net awards for Q1 2025 totaled $10.8 billion and backlog totaled $92.8 billion. Significant new awards included $4.6 billion for restricted programs and $1.1 billion for the F-35 program.

3. 03

   The company said net cash used in operating activities for Q1 2025 was $(1,565) million and free cash flow was $(1,821) million. It attributed the result mainly to changes in trade working capital, and said operating cash flows are generally more heavily weighted toward the second half of the year.

4. 04

   The company said it sees full-year 2025 sales of $42,000 to $42,500 million and free cash flow of $2,850 to $3,250 million. Segment operating income guidance is $4,200 to $4,350 million, compared with prior guidance of $4,650 to $4,800 million.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.